Korro Bio, Inc. financial data

Symbol
KRRO on Nasdaq
Location
60 First Street, 2 Nd Floor, Suite 250, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 867 % -13.3%
Return On Equity -61.5 % +34%
Return On Assets -42.9 % +10.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.39M shares +0.99%
Common Stock, Shares, Outstanding 9.39M shares +1.2%
Entity Public Float 237M USD +1849%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 9.39M shares +4.5%
Weighted Average Number of Shares Outstanding, Diluted 9.39M shares +4.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.46M USD
Research and Development Expense 73.7M USD +22.5%
General and Administrative Expense 31.1M USD -1.08%
Operating Income (Loss) -98.6M USD -7.57%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91.3M USD -7.05%
Income Tax Expense (Benefit) 95K USD +102%
Net Income (Loss) Attributable to Parent -91.4M USD -7.1%
Earnings Per Share, Basic -9 USD/shares -112%
Earnings Per Share, Diluted -9 USD/shares -112%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.6M USD -63.1%
Marketable Securities, Current 62.8M USD -5.33%
Assets, Current 103M USD -37.3%
Property, Plant and Equipment, Net 25.4M USD +2.8%
Operating Lease, Right-of-Use Asset 23.5M USD -5.34%
Other Assets, Noncurrent 3.21M USD +20.2%
Assets 180M USD -27.7%
Accounts Payable, Current 5.16M USD -9.25%
Employee-related Liabilities, Current 1.87M USD -43.8%
Accrued Liabilities, Current 5.66M USD -8.4%
Liabilities, Current 17.2M USD +39.3%
Operating Lease, Liability, Noncurrent 42.2M USD +11.1%
Other Liabilities, Noncurrent 1.44M USD +21.7%
Liabilities 65.3M USD +26.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 177K USD +743%
Retained Earnings (Accumulated Deficit) -316M USD -40.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 115M USD -41.9%
Liabilities and Equity 180M USD -27.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.5M USD -11.7%
Net Cash Provided by (Used in) Financing Activities 172K USD +23.7%
Net Cash Provided by (Used in) Investing Activities 32.8M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 9.39M shares +1.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.5M USD
Deferred Tax Assets, Valuation Allowance 168M USD +15.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 179M USD +16.4%
Operating Lease, Liability 44.6M USD +16%
Depreciation 1.2M USD +71.4%
Payments to Acquire Property, Plant, and Equipment 119K USD -97.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91.2M USD -6.7%
Lessee, Operating Lease, Liability, to be Paid 71M USD +1.87%
Property, Plant and Equipment, Gross 35.2M USD +3.52%
Operating Lease, Liability, Current 2.43M USD +431%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.56M USD +2.94%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.34M USD +17.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26.4M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.78M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 94.2M USD +17.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.01M USD
Additional Paid in Capital 431M USD +1.95%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 10.3M USD +33.9%
Share-based Payment Arrangement, Expense 6.39M USD +84.5%
Interest Expense 596K USD -28.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%